113 related articles for article (PubMed ID: 10716087)
1. Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient.
Tejan-Sie SA; Avery RK; Mossad SB
Scand J Infect Dis; 2000; 32(1):94-6. PubMed ID: 10716087
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow infection with Mycobacterium fortuitum in a diabetic patient.
Satti L; Abbasi S; Sattar A; Ikram A; Manzar MA; Khalid MM
J Coll Physicians Surg Pak; 2011 Aug; 21(8):500-2. PubMed ID: 21798140
[TBL] [Abstract][Full Text] [Related]
3. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
Wallace RJ; Swenson JM; Silcox VA; Bullen MG
J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium fortuitum: an iatrogenic cause of soft tissue infection in surgery.
Muthusami JC; Vyas FL; Mukundan U; Jesudason MR; Govil S; Jesudason SR
ANZ J Surg; 2004 Aug; 74(8):662-6. PubMed ID: 15315567
[TBL] [Abstract][Full Text] [Related]
5. Chronic multifocal Mycobacterium fortuitum osteomyelitis following penetrating plantar trauma.
Cruz AT; Antekeier SB
Am J Orthop (Belle Mead NJ); 2012 Aug; 41(8):E109-11. PubMed ID: 22900254
[TBL] [Abstract][Full Text] [Related]
6. Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum.
Kunin M; Salamon F; Weinberger M; Genkin I; Sagie A; Tur-Kaspa R
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):539-41. PubMed ID: 12172746
[TBL] [Abstract][Full Text] [Related]
7. Activity of various drugs alone or in combination against Mycobacterium fortuitum.
Santos A; Cremades R; Rodríguez JC; Garcia-Pachon E; Ruiz M; Royo G
J Infect Chemother; 2010 Feb; 16(1):64-7. PubMed ID: 20063030
[TBL] [Abstract][Full Text] [Related]
8. Skin, subcutaneous tissue, and allograft infection with Mycobacterium fortuitum in a renal transplant recipient.
Mushtaq RF; Bappa A; Ahmad M; AlShaebi F
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1248-50. PubMed ID: 25394443
[TBL] [Abstract][Full Text] [Related]
9. Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
Thorell EA; Sharma M; Jackson MA; Selvarangan R; Woods GM
J Pediatr Hematol Oncol; 2006 Oct; 28(10):678-81. PubMed ID: 17023829
[TBL] [Abstract][Full Text] [Related]
10. Lasiodiplodia species fungal osteomyelitis in a multiple myeloma patient.
Mohan M; Shalin SC; Kothari A; Rico JC; Caradine K; Burgess M
Transpl Infect Dis; 2016 Oct; 18(5):761-764. PubMed ID: 27391908
[TBL] [Abstract][Full Text] [Related]
11. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
Hu FR; Luh KT
Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
[TBL] [Abstract][Full Text] [Related]
12. A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Esteban J; Gadea I; Torres MV; Cabria F; Rollan E; Santos-O'Connor FG; Fernández-Roblas R; Soriano F
J Chemother; 2002 Dec; 14(6):547-53. PubMed ID: 12583544
[TBL] [Abstract][Full Text] [Related]
13. The use of amikacin in the treatment of primary cutaneous mycobacteriosis due to Mycobacterium fortuitum.
Ena P; Zanetti S; Sechi LA; Fadda G; Leigheb G
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):66-7. PubMed ID: 10188156
[No Abstract] [Full Text] [Related]
14. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
Shih MH; Huang FC
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):223-9. PubMed ID: 20811055
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium chelonae and Mycobacterium fortuitum infection following open fracture: a case report and review of the literature.
Kwan K; Ho ST
Indian J Med Microbiol; 2010; 28(3):248-50. PubMed ID: 20644316
[TBL] [Abstract][Full Text] [Related]
16. Complicated skin and soft tissue infection with Mycobacterium fortuitum following excision of a sebaceous cyst in Taiwan.
Tsai SC; Chen LH; Liao HH; Chiang CY; Lin WL; Chen SC; Tsao SM; Hung HC; Lee YT
J Infect Dev Ctries; 2016 Dec; 10(12):1357-1361. PubMed ID: 28036317
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis and Mycobacterium fortuitum osteomyelitis of the foot and septic arthritis of the ankle in an immunocompetent patient.
Lazzarini L; Amina S; Wang J; Calhoun JH; Mader JT
Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):468-70. PubMed ID: 12111605
[TBL] [Abstract][Full Text] [Related]
18. Resistance profile of strains of Mycobacterium fortuitum isolated from clinical specimens.
Santos DR; Lourenço MC; Coelho FS; Mello FC; Duarte RS
J Bras Pneumol; 2016; 42(4):299-301. PubMed ID: 27832239
[No Abstract] [Full Text] [Related]
19. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].
Régnier S; Martinez V; Veziris N; Bonvallot T; Meningaud JP; Caumes E
Ann Dermatol Venereol; 2008; 135(8-9):591-5. PubMed ID: 18789296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
